Top Markets
#1 Helium Helium +111.70%
#2 MowCat MowCat +87.96%
#3 Seeker Seeker +59.64%
#4 UnifAI Network UnifAI Network +35.38%
#5 TENDIES TENDIES +30.15%
#6 pipedog pipedog +23.48%
#7 Zylo Ecosystem Zylo Ecosystem +22.00%
#8 Bounce Bounce +20.25%
#9 Tensor Tensor +19.72%
#10 Pons Pons +19.15%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
Senores Pharmaceuticals Ltd. Senores Pharmaceuticals Ltd.

Senores Pharmaceuticals Ltd.

SENORES
Rank in Stocks #11030
Established in 2017 and headquartered in Ahmedabad, India, Senores... Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
Share Price
$16.36
Last synced: 2026-08-28
Market Cap
$753.27M
Change (1 day)
0.51%
Change (1 year)
108.95%
Country
IN
Trade Senores Pharmaceuticals Ltd. (SENORES)

Category

Healthcare
P/E ratio for Senores Pharmaceuticals Ltd. (SENORES)
P/E ratio as of 2026 TTM: 0
According to Senores Pharmaceuticals Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Senores Pharmaceuticals Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 39.54 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 30.10 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 70.28 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 22.25 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 107.81 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.